Identifying value

We apply technical, commercial and legal know-how to identify ideas that can become valuable assets for our clients.

Vision realised.

home slide

Building understanding

We work closely with our clients to understand their individual needs - from the immediate to the long-term.

Vision realised.

img

Maximising returns

We deliver advice that's proven, pragmatic and focused on delivering the right outcome for each client.

Vision realised.

img

About us

Slingsby Partners LLP was formed with one key vision: to enable clients to more easily realise their business objectives through the use of IP - and we have brought together a team of outstanding IP professionals to achieve that goal. From start-up to established market leader - and wherever your organisation sits on the technology spectrum - we can help you generate lasting value from your ideas.

About us

Our Approach

Our attorneys have a long track record of working alongside remarkable businesses to help them identify, protect and manage their intellectual property. Whether running a brainstorming session to capture the innovations in a new project or supporting a client through a dispute with a competitor, our goal is to make intellectual property work for our clients. We are particularly proud that the great majority of our instructions come through recommendations from existing clients.

Two team members talking in a meeting room

News & insights

23 Sep 2022

EPO now offering an additional search service on allowance of a European application

On 1 September 2022, the EPO started offering a search service additional to standard search and examination. The additional service will focus on searching for national patent applications that need not be taken into account during prosecution at the EPO, but could affect validity of national parts of a granted European patent or a Unitary Patent.

Read more

07 Sep 2022

Is this the start of COVID-19 patent wars?

Moderna has filed a patent infringement lawsuit against Pfizer and BioNTech (Pfizer’s German partner) over mRNA technology Moderna claims to have developed prior to the COVID-19 pandemic, as it seems that the cooperation shown during the COVID-19 pandemic that led to such rapid vaccine development is starting to wear off.

Read more

14 Jul 2022

Appeal Oral Proceedings by Video Conference

The EPO has reaffirmed that Appeal Board oral proceedings can be held by videoconference despite disagreement from one or both parties during a general emergency. This still appears to be considered a temporary measure until restrictions that have arisen due to the pandemic fully subside.

Read more

‘Very strong practice with fantastic technical knowledge, international coverage and commercial pragmatism.‘

Legal 500

2022

bg